Tenofovir Df + Emtricitabine + Rilpivirine Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: TDF – 300 mg + Emtricitabine – 200 mg + Rilpivirine – 25 mg
Reference Brands: Complera(US); Eviplera(EU)
Category: Anti Viral
Tenofovir DF + Emtricitabine + Rilpivirine, sold as Complera (US) and Eviplera (EU), is a once-daily HIV-1 treatment combining three antiretrovirals in one tablet. It’s FDA and EMA approved and must be taken with food.
Product Description:
Tenofovir Disoproxil Fumarate (TDF) + Emtricitabine + Rilpivirine is a once-daily, fixed-dose combination used for the treatment of HIV-1 infection in treatment-naïve adults and adolescents. Marketed under the brand names Complera (US) and Eviplera (EU), it combines three powerful antiretroviral agents: TDF (a nucleotide reverse transcriptase inhibitor), Emtricitabine (an NRTI), and Rilpivirine (a non-nucleoside reverse transcriptase inhibitor). This single-tablet regimen simplifies HIV treatment, enhances patient adherence, and effectively suppresses viral load. Approved by the FDA and EMA, it is recommended for patients without resistance to any of its components and should be taken with a meal for optimal absorption.
Tenofovir Df + Emtricitabine + Rilpivirine — third party manufacturing & bulk supply
Tenofovir Df + Emtricitabine + Rilpivirine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Tenofovir Df + Emtricitabine + Rilpivirine is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Tenofovir Df + Emtricitabine + Rilpivirine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Tenofovir Df + Emtricitabine + Rilpiviri... →Frequently Asked Questions
Tenofovir disoproxil fumarate, emtricitabine, and rilpivirine are used together as a complete regimen for the treatment of HIV-1 infection. This combination helps reduce viral load, increase CD4 cell counts, and prevent the progression of HIV when taken consistently. It is generally prescribed for treatment-naïve patients with stable viral levels and no resistance.
It is made from three antiretroviral agents: Tenofovir disoproxil fumarate, a nucleotide reverse transcriptase inhibitor; Emtricitabine, a nucleoside reverse transcriptase inhibitor; and Rilpivirine, a non-nucleoside reverse transcriptase inhibitor. Together, these ingredients block viral replication at multiple stages.
Its commonly known trade name is Complera in the USA and Eviplera in the EU and UK.
This combination is originally manufactured by Gilead Sciences in partnership with Janssen Pharmaceuticals for the rilpivirine component.
The generic name is Tenofovir disoproxil fumarate + Emtricitabine + Rilpivirine.
Brand names include Complera (USA) and Eviplera (EU/UK).
It is primarily manufactured in the USA and Europe by Gilead Sciences, with additional licensed generic manufacturing in India by several approved pharmaceutical companies.
Related Products
Dolutegravir + Rilpivirine
Strength:
50 mg / 25 mg
Form: Tablet
Reference Brands: Juluca(EU & US)
View Details
Tenofovir Df + Emtricitabine + Elvitegravir + Cobicistat
Strength:
Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TDF – 300 mg
Form: Oral tablet (film-coated)
Reference Brands: Stribild (US & EU)
View Details
Dolutegravir + Abacavir + Lamivudine
Strength:
50 mg / 600 mg / 300 mg
Form: Tablet
Reference Brands: Triumeq(US & EU)
View Details
Tenofovir Af + Emtricitabine
Strength:
Tenofovir AF 25 mg + Emtricitabine 200 mg
Form: Tablet
Reference Brands: Descovy(EU & US)
View Details
Quick Response Guaranteed | Verified Suppliers
